Net Cash Provided by (Used in) Financing Activities of BIOTRICITY INC. from 30 Nov 2014 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOTRICITY INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Nov 2014 to 30 Jun 2025.
  • BIOTRICITY INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Jun 2025 was $435,705, a 50% decline year-over-year.
  • BIOTRICITY INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1,929,259, a 71% decline from 2023.
  • BIOTRICITY INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6,741,685, a 237% increase from 2022.
  • BIOTRICITY INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2,001,603, a 92% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIOTRICITY INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $435,705 -$432,475 -50% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q2 2024 $868,180 -$460,965 -35% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2026 Q1
Q2 2023 $1,329,145 +$2,162,366 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2025 Q1
Q2 2022 $833,221 -$1,414,309 -243% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2024 Q1
Q2 2021 $581,088 -$992,899 -63% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2023 Q1
Q2 2020 $1,573,987 +$244,185 +18% 01 Apr 2020 30 Jun 2020 10-Q/A 17 Aug 2021 2022 Q1
Q2 2019 $1,329,802 +$778,967 +141% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2021 Q1
Q2 2018 $550,835 -$1,375,945 -71% 01 Apr 2018 30 Jun 2018 10-Q 15 Aug 2019 2020 Q1
Q2 2017 $1,926,780 +$1,253,575 +186% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2019 Q1
Q1 2017 $1,486,102 +$1,260,378 +558% 01 Jan 2017 31 Mar 2017 10-KT 29 Jun 2017 2017 FY
Q2 2016 $673,205 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2018 Q1
Q1 2016 $225,724 -$9,655 -4.1% 01 Jan 2016 31 Mar 2016 10-KT 29 Jun 2017 2017 FY
Q4 2015 $19,357 +$15,753 +437% 01 Sep 2015 31 Dec 2015 10-K 13 Apr 2016 2015 FY
Q1 2015 $235,379 01 Jan 2015 31 Mar 2015 10-Q 19 May 2016 2016 Q1
Q4 2014 $3,604 01 Sep 2014 30 Nov 2014 10-Q 21 Dec 2015 2016 Q1

BIOTRICITY INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,929,259 -$4,812,426 -71% 01 Apr 2024 31 Mar 2025 10-K/A 18 Jul 2025 2025 FY
2023 $6,741,685 +$4,740,082 +237% 01 Apr 2023 31 Mar 2024 10-K/A 18 Jul 2025 2025 FY
2022 $2,001,603 -$23,166,627 -92% 01 Apr 2022 31 Mar 2023 10-K 27 Jun 2024 2024 FY
2021 $25,168,230 +$12,964,750 +106% 01 Apr 2021 31 Mar 2022 10-K 29 Jun 2023 2023 FY
2020 $12,203,480 +$3,324,311 +37% 01 Apr 2020 31 Mar 2021 10-K 14 Jul 2022 2022 FY
2019 $8,879,169 +$4,322,625 +95% 01 Apr 2019 31 Mar 2020 10-K 22 Jun 2021 2021 FY
2018 $4,556,544 -$732,737 -14% 01 Apr 2018 31 Mar 2019 10-K 15 Jul 2020 2020 FY
2017 $5,289,281 +$3,109,081 +143% 01 Apr 2017 31 Mar 2018 10-K 16 Jul 2019 2019 FY
2016 $2,180,200 +$183,572 +9.2% 01 Jan 2016 31 Dec 2016 10-KT 29 Jun 2017 2017 FY
2015 $1,996,628 +$280,933 +16% 01 Jan 2015 31 Dec 2015 10-KT 29 Jun 2017 2017 FY
2014 $1,715,695 01 Jan 2014 31 Dec 2014 8-K 13 Apr 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.